共 247 条
[1]
Trayes KP(2021)Breast cancer treatment Am Fam Physician 104 171-178
[2]
Cokenakes SEH(2020)Jemal A (2020) Cancer statistics CA Cancer J Clin 70 7-30
[3]
Siegel RL(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249
[4]
Miller KD(2021)Current and future management of HER2-positive metastatic breast cancer JCO Oncol Pract 17 594-604
[5]
Sung H(2022)Clinical trial data and emerging strategies: HER2-positive breast cancer Breast Cancer Res Treat 193 281-291
[6]
Ferlay J(2021)The management of HER2-positive early breast cancer: current and future therapies Asia Pac J Clin Oncol 17 3-12
[7]
Siegel RL(2013)Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer Breast Cancer Res Treat 142 549-558
[8]
Laversanne M(2022)Benefits of neoadjuvant therapy compared with adjuvant chemotherapy for the survival of patients with HER2-positive breast cancer: a retrospective cohort study at FUSCC Breast 63 177-186
[9]
Soerjomataram I(2021)Pertuzumab cardiotoxicity in patients with HER2-positive cancer: a systematic review and meta-analysis CJC Open 3 1372-1382
[10]
Jemal A(2019)Trastuzumab-induced cardiomyopathy Cardiol Clin 37 407-418